BBP (Virtus Biotech ETF) Stock Analysis - Analyst Ratings

Virtus Biotech ETF (BBP) is a publicly traded the market company. As of May 21, 2026, BBP trades at $90.21 with a market cap of $0 and a P/E ratio of 0.00. BBP moved +3.43% today. Year to date, BBP is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces BBP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate BBP?

The average price target is $0.00.

BBP Key Metrics

Key financial metrics for BBP
MetricValue
Price$90.21
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume140.02K
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

BBP Analyst Consensus

BBP analyst coverage data. Average price target: $0.00.

Latest BBP News

Common questions about BBP

What do analysts rate BBP?
The average price target is $0.00.
Does Rallies show BBP price targets?
Yes. Rallies tracks BBP analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is BBP research on Rallies investment advice?
No. Rallies provides research, data, and educational context for BBP. It does not provide personalized investment advice.
BBP

BBP